Kairos Pharma Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$0.34

-0.02 (-5.78%)

As of Aug 14, 4:20 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +2,270.3% upside

Low Target $5.03

Average Target $8.04

High Target $9.33

Current Price $0.34

Current
$0.34

Target
$8.04

$5.03 $8.04 avg $9.33

Scenario Analysis

Bear Case

$5.03

1,382.9%

Low target

Base Case

$8.04

+2,270.3%

Avg target

Bull Case

$9.33

+2,650.6%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$2.11

-83.9% from high

52-Week Low

$0.27

+25.9% from low

Target vs 52W High

$8.04

+281.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%